THE NICHOLAS CONOR INSTITUTE APPOINTS BILL HAYDEN TO ITS INDUSTRY ADVISORY BOARD
Life Science/Healthcare Industry Veteran to Help Increase Collaborations with
Industry, Government and Academia for childhood cancer
San Diego, CA / Berkeley, CA / Montreal, Canada - January 13, 2016
The Nicholas Conor Institute (TNCI - www.tnci.org),
a leading childhood cancer collaborative research foundation and advocate for childhood cancer research
funding, today formally announced the appointment of William Hayden to its
Industry Advisory Board.
"We are delighted to have Bill on-board and his help on the translational research
side in setting up industry, government and academic collaborations, as well on the
advocacy side, in regards to increase funding for pediatric cancer to support further
development of promising, innovative treatments and much needed therapy
decision support tools", said Dr. Beth Anne Baber, CEO and Co-founder of TNCI.
Dr. Baber went on to say, "We have known Bill for a number of years and have
often gone to him as a sounding board and benefitted from his industry knowledge,
his advocacy experience, and his marketing background. We are thrilled to have
him formally on-board."
Bill Hayden began his marketing career at Citizens Health/Medco Containment in
Boston, the largest mail-order prescription drug and cost containment firm at that
time. He then went on to work for Readers Digest in Direct Marketing in their
Recorded Music Division followed by senior management positions with a number
of start-up software firms in the drug discovery and informatics arena. He is
currently, Senior Director - Global Business Development for IO Informatics
IOI is a recognized industry leader in solving Big Data
and Precision Medicine challenges through its software and services that provide
uniquely efficient data integration and transformative knowledge applications. Bill
has been involved in a number of not-for-profit organizations, including serving on
the Board of the Lucky Harvest Project, which offers therapeutic horseback riding
lessons for children with autism, Down's Syndrome and physical disabilities.
"I am honored to be asked to join TNCI in an advisory capacity. Beth Anne Baber
is both knowledgeable of the scientific research required due to her background
from working at the Salk Institute and is passionate about advocating for the kids
afflicted with cancer and their families as she herself is the mother of a childhood
cancer survivor. I have learned so much about childhood cancer both on the
medical and personal impact areas over the years from Beth Anne and TNCI and
hope that my own knowledge can make a positive impact," stated Bill Hayden
Bill went on to say, "Childhood Cancer is THE number one killer of children by a
disease in the USA. It not only robs the children of their lives at an early age, but
also deprives them of their future years. Each family is devastated both
emotionally and financially when their child is diagnosed with cancer. I believe
there is an immediate need for the government to declare childhood cancer as a
national priority. The current push is to have the Congress and Senate fund the
National Cancer Institute more in the area of Childhood Cancer Research.
Presently only 4% of the NCI's budget goes towards childhood cancer research,
while the remaining 96% is spent on adult cancer research. Childhood cancers are
different from adult cancers; kids are being treated with therapies developed for
adults; I strongly feel that this is NOT RIGHT. We need to change the way research
is funded and provide industry market appropriate incentives to usher cures to the
clinic for kids"
About The Nicholas Conor Institute
THE NICHOLAS CONOR INSTITUTE (TNCI) is a 501(c)(3) not-for-profit translational
medical research and commercialization organization that concentrates exclusively
on cancers common to children, adolescents and young adults. We accelerate
research and development of diagnostic tools and treatments, translate them into
clinical products, and facilitate their placement into the clinic.
ABOUT IO INFORMATICS
IO is at the forefront of the semantic technology wave. The Company provides
software and services for uniquely efficient data integration and transformative
knowledge applications in life sciences, biotechnology, pharmaceutical, and medical
environments. IO is headquartered in Berkeley, California with offices in Canada
and Europe. IOI works with life science and healthcare customers in industry,
academia and not-for-profit foundations.
For more information visit: http://www.io-informatics.com